LUIS ORTEGA: Open Payments
NPI 1831296904 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$516 in 7 payments from 4 companies in 2025. Trend: 2023 $227 · 2024 $702 · 2025 $516
Food & beverage: $516
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $275 |
| Neurocrine BioSciences, Inc. | 1 | $175 |
| ACADIA Pharmaceuticals Inc | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: INGREZZA, REXULTI, ABILIFY ASIMTUFII, NUPLAZID, COBENFY.
Industry payments across NV — which companies pay providers there.
